Anavex Life Sciences Corp (AVXL)

[kevli33]

Putting a face to the name (Prof. Terry O'brien)

Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndrome (AVATAR)

Study will incorporate genomic precision medicine ANAVEX®2-73-specific biomarkers

NEW YORK – June 6, 2019

Terence J. O’Brien, MB, BS, MD, FRACP, FRCPE, FAHMS, FAES, principal investigator of the AVATAR study and Van Cleef Roet Professor of Medicine (Neurology) and Head, Department of Neuroscience & Deputy Head, Central Clinical School, Monash University as well as Program Director – Alfred Brain, Director of Neurology & Deputy Director of Research, Alfred Health stated, ”Rett syndrome is a devastating disease for patients and families, for which there are currently no treatments that improve the course of the disease. There is an urgent need for high quality, evidence-based treatments for Rett syndrome patients.”

https://www.anavex.com/anavex-life-sciences-announces-first-patient-dosed-in-phase-2-clinical-trial-of-anavex2-73-for-the-treatment-of-rett-syndrome-avatar/

" rel="nofollow" target="_blank">https://www.youtube.com/watch?v=